Study Published On Yale Journal Shows Cannabis Provides Immediate Relief For Symptoms Of Depression & Other Mental Health Issues

Original publication in 2020.

According to a research study published by the University Of New Mexico and Releaf App in the Yale Journal of Biology and Medicine, cannabis flower may be effective in providing immediate relief for the symptoms of depression – a condition affecting roughly 1 in 5 adults in the U.S., and often leading to other ailments like cancer, substance use disorders, anxiety disorders, schizophrenia, dementia, diabetes, cardiovascular disease, and chronic pain.

“The findings suggest that, at least in the short term, the vast majority of patients that use cannabis experience antidepressant effects, although the magnitude of the effect and extent of side effect experiences vary with chemotypic properties of the plant,” the paper reads.

See also: Far More Potent Than THC And CBD: Dr. Raphael Mechoulam, 'Father Of Cannabis Research,' Explains His Latest Discovery

The Research

The study, titled “The Effectiveness of Cannabis Flower for Immediate Relief from Symptoms of Depression,” was led by the founders of University of New Mexico’s Marijuana Research Fund, Jacob Vigil, Psychology Associate Professor at UNM, and Sarah See Stith, Economics Assistant Professor at UNM.

After reviewing 5,876 outcomes reported anonymously by 1,819 individuals tracking their cannabis use for treating depression through the Releaf App, the researchers concluded that, on average, patients reported an improvement in symptoms of nearly 4 points on a scale of 0 to 10, just moments after consuming whole, dried, natural cannabis flower – widely known as cannabis buds.

See also: Drug Testing At Work Is A Thing Of The Past, Study Finds

By means of comparison, readers should know that conventional pharmaceuticals used for the treatment of the symptoms of depression (like monoamine oxidase inhibitors, tricyclics antidepressants, selective serotonin-reuptake inhibitors, and selective norepinephrine reuptake inhibitors) normally take several weeks, or even months, to start causing significant relief. Furthermore, the study notes that the potential side effects associated with these traditional pharma products include sedation, agitation, anxiety, anorgasmia, demotivation, and suicidal ideation.

“One of the more interesting findings from this study is that cannabis flower with relatively high levels of tetrahydrocannabinol or THC is particularly associated with immediate reductions in the intensity of depressive feelings,” said Jacob Miguel Vigil. “The differences in time-to-effect and relative side effect prevalence across products and users could arise from other antidepressant and synergistic compounds in the plant beyond THC or cannabidiol (CBD), including minor cannabinoids, terpenes and flavonoids.”

Further Detail

Per the study, most of the patients using natural cannabis flower products to treat their depression symptoms reported antidepressant effects. However, the magnitude of these effects and extent of experienced side effects varied alongside the properties of each plant.

The investigators also discovered that up to one in five individuals who used cannabis flower containing high levels of THC experienced some negative side effects, such as feeling unmotivated. Having said this, the report adds individuals in the study were three times as likely to experience positive effects like happiness, optimism, peacefulness, and relaxation.

See also: Far More Potent Than THC And CBD: Dr. Raphael Mechoulam Explains His Latest Discovery

“Over the past few years it is becoming clear that individuals using Releaf App are tracking their mental health symptoms in more detail to better understand how cannabis may help provide them with relief,” said Keenan Keeling, CEO of MoreBetter the company behind Releaf App. “Historically, we’ve seen cannabis efficacy studies related to chronic physical ailments such as pain, cancer, and epilepsy. It is becoming increasingly important and relevant to better understand how cannabis affects mental health disorders like depression.”

“With no end to the depression epidemic in site, and given the limitations and potential severe negative side effects of conventional antidepressant medications, there is a real need for people to be able to treat mood disturbances with natural, safe, and effective medications, and cannabis checks off all three boxes,” concluded Vigil.

Lead image by Lelen Ruete.

This article was originally published on Forbes, and republished here with permission.

Original publication: 2020.

Posted In: BiotechCannabisNewsHealth CareMarketsGeneralCannabis DepressionICYMIReleaf AppUniversity Of New Mexico
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...